The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|October 2, 2015
- Pharmaceutical Technology-10-02-2015
- Volume 38
- Issue 10
Pharmaceutical Technology, October 2015 Issue (PDF)
Click the title above to open the Pharmaceutical Technology October 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 11 years ago
Identifying Powder Properties that Define Process Performanceabout 11 years ago
Connecting MES to Process Controlabout 11 years ago
Parenteral Packaging Advancesabout 11 years ago
Serialization Shake Outabout 11 years ago
Investigating Biologicsabout 11 years ago
Advances in Fluorination Chemistry for API Synthesisabout 11 years ago
Small-Molecule API CMOs Are Thrivingabout 11 years ago
Modular Platform for Agitator Bead Mill Optimizes Grindingabout 11 years ago
Self-Contained Laboratory Homogenizer Prepares Injectable DrugsAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement